Vaxart, Inc. (VXRT)
0.43
+0.01
(+1.27%)
USD |
OTCM |
Oct 30, 16:00
Vaxart Price : 0.43 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 0.427 | 0.4399 | 0.39 | 0.43 | 323223.0 |
| Oct 29, 2026 | 0.3995 | 0.437 | 0.3995 | 0.4246 | 245738.0 |
| Oct 28, 2026 | 0.40 | 0.44 | 0.3501 | 0.408 | 576971.0 |
| Oct 27, 2026 | 0.40 | 0.4199 | 0.398 | 0.399 | 207933.0 |
| Oct 26, 2026 | 0.41 | 0.442 | 0.398 | 0.405 | 352786.0 |
| Oct 23, 2026 | 0.449 | 0.4499 | 0.41 | 0.41 | 339460.0 |
| Oct 22, 2026 | 0.4797 | 0.48 | 0.44 | 0.441 | 330887.0 |
| Oct 21, 2026 | 0.4898 | 0.4934 | 0.47 | 0.475 | 117102.0 |
| Oct 20, 2026 | 0.453 | 0.494 | 0.453 | 0.49 | 89499.00 |
| Oct 19, 2026 | 0.45 | 0.525 | 0.4456 | 0.4755 | 792161.0 |
| Oct 16, 2026 | 0.47 | 0.4911 | 0.44 | 0.4527 | 201772.0 |
| Oct 15, 2026 | 0.445 | 0.469 | 0.4405 | 0.455 | 184782.0 |
| Oct 14, 2026 | 0.455 | 0.46 | 0.455 | 0.4575 | 217910.0 |
| Oct 13, 2026 | 0.44 | 0.4699 | 0.42 | 0.4566 | 329050.0 |
| Oct 12, 2026 | 0.431 | 0.4742 | 0.43 | 0.4399 | 349881.0 |
| Oct 09, 2026 | 0.44 | 0.45 | 0.431 | 0.4344 | 198223.0 |
| Oct 08, 2026 | 0.44 | 0.44 | 0.4315 | 0.4345 | 267426.0 |
| Oct 07, 2026 | 0.4306 | 0.4400 | 0.401 | 0.432 | 354923.0 |
| Oct 06, 2026 | 0.42 | 0.45 | 0.415 | 0.4363 | 121056.0 |
| Oct 05, 2026 | 0.435 | 0.4473 | 0.40 | 0.42 | 329590.0 |
| Oct 02, 2026 | 0.4535 | 0.46 | 0.4301 | 0.437 | 239377.0 |
| Oct 01, 2026 | 0.45 | 0.4623 | 0.4306 | 0.44 | 339926.0 |
| Sep 30, 2026 | 0.45 | 0.4635 | 0.43 | 0.45 | 161720.0 |
| Sep 29, 2026 | 0.454 | 0.4693 | 0.44 | 0.4502 | 297712.0 |
| Sep 28, 2026 | 0.45 | 0.46 | 0.44 | 0.4578 | 124977.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.84 |
| Amgen, Inc. | 466.01 |
| Anika Therapeutics, Inc. | 20.95 |
| BioCryst Pharmaceuticals, Inc. | 8.47 |
| Imunon, Inc. | 0.91 |
Price Related Metrics
| PE Ratio | 2.704 |
| PS Ratio | 0.4218 |
| Price to Book Value | 1.268 |
| Price to Free Cash Flow | 3.072 |
| Earnings Yield | 36.98% |
| Market Cap | 104.42M |
| Operating PE Ratio | 2.588 |
| Normalized PE Ratio | 2.704 |